Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The Clinical Respiratory Journal|June 21, 2023
A retrospective comparison between digital to conventional drainage systems for secondary spontaneous pneumothorax related to diffuse interstitial lung diseaseKohei Shikano, Mitsuhiro Abe, Ryutaro Hirama, et al.
Molecular Cell|June 11, 2011
Switching Cdk2 on or off with small molecules to reveal requirements in human cell proliferationKarl A Merrick, Lara Wohlbold, Chao Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2012
Chemical-genetic analysis of cyclin dependent kinase 2 function reveals an important role in cellular transformation by multiple oncogenic pathwaysDai Horiuchi, Noelle E Huskey, Leonard Kusdra, et al.
Diagnostics (Basel, Switzerland)|June 13, 2025
Impact of Storage Conditions on Bronchoalveolar Lavage Fluid Analysis: A Human StudyYu Shionoya, Kanae Maruyama, Takeshi Kawasaki, et al.
The Journal of Biological Chemistry|May 8, 2009
Up-regulation of miR-21 by HER2/neu signaling promotes cell invasionTzu-Hsuan Huang, Fangting Wu, Gabriel B Loeb, et al.
FASEB Bioadvances|January 23, 2026
Increased Orexin by High Concentration of Sevoflurane Enhances the Suprahyoid Muscle Activity Involves in Gasping-Like Respiration of MiceYoko Irukayama-Tomobe, Jun-Dal Kim, Hisayo Jin, et al.
The Journal of Experimental Medicine|March 21, 2012
MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibitionDai Horiuchi, Leonard Kusdra, Noelle E Huskey, et al.
Communications Medicine|February 20, 2024
S100A8/A9 predicts response to PIM kinase and PD-1/PD-L1 inhibition in triple-negative breast cancer mouse modelsLauren R Begg, Adrienne M Orriols, Markella Zannikou, et al.
Biorxiv : the Preprint Server for Biology|October 4, 2023
S100A8/A9 predicts triple-negative breast cancer response to PIM kinase and PD-1/PD-L1 inhibitionLauren R Begg, Adrienne M Orriols, Markella Zannikou, et al.
Nature Medicine|November 8, 2016
PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expressionDai Horiuchi, Roman Camarda, Alicia Y Zhou, et al.
Pageof 3